Stockhub

Aileron Therapeutics, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 August 2022

  • curprev 13:1213:12, 29 August 2022 >Nick 1,184 bytes +1,184 Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of AL..."
Retrieved from "https://stockhub.co/research/Aileron_Therapeutics,_Inc."